A major study by Maliar et al., demonstrated that a CAR-T construct targeting the putative CSC protein CD24 in pancreatic ductal adenocarcinoma (PDAC) improved overall survival (OS) and reduced metastasis in orthotopic patient-derived xenografts and in CAPAN-1-derived xenografts. Here, CD24 is linked to pancreatic ductal adenocarcinoma.